GCP
AQST icon

GSA Capital Partners’s Aquestive Therapeutics AQST Stock Holding History

GSA Capital Partners’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$484K Buy
+116,260
New +$489K 0.03% 1025
2025
Q4 		– Sell
-241,359
Closed -$1.35M – 1657
2025
Q3 		$1.35M Buy
241,359
+54,667
+29% +$236K 0.11% 230
2025
Q2 		$618K Buy
+186,692
New +$536K 0.04% 769
2024
Q4 		– Sell
-137,151
Closed -$683K – 1585
2024
Q3 		$683K Buy
137,151
+115,223
+525% +$448K 0.05% 708
2024
Q2 		$57K Buy
+21,928
New +$73.2K ﹤0.01% 1561
2023
Q4 		– Sell
-100,854
Closed -$154K – 1481
2023
Q3 		$154K Buy
100,854
+86,902
+623% +$149K 0.01% 1333
2023
Q2 		$23K Buy
+13,952
New +$25.2K ﹤0.01% 1441
2022
Q4 		– Sell
-13,704
Closed -$16K – 1443
2022
Q3 		$16K Buy
+13,704
New +$15.5K ﹤0.01% 1452
2022
Q2 		– Sell
-34,769
Closed -$91K – 1380
2022
Q1 		$91K Sell
34,769
-63,033
-64% -$184K 0.01% 1304
2021
Q4 		$380K Sell
97,802
-199,427
-67% -$1M 0.05% 775
2021
Q3 		$1.3M Buy
297,229
+199,428
+204% +$782K 0.13% 181
2021
Q2 		$388K Sell
97,801
-109,808
-53% -$439K 0.04% 790
2021
Q1 		$1.08M Buy
+207,609
New +$1.1M 0.18% 120
2019
Q2 		– Sell
-11,400
Closed -$79K – 1423
2019
Q1 		$79K Buy
+11,400
New +$79.9K 0.01% 1346

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

GSA Capital Partners's AQST Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Aquestive Therapeutics (AQST) in Q2 2026: 116,260 shares worth $484K. The stake represents 0.03% of the portfolio and ranks #1025 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in AQST as recently as Q3 2025.

GSA Capital Partners first reported a position in AQST in Q1 2019 and has held it in 14 quarters since. The position peaked at $1.35M in Q3 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • GSA Capital Partners held 116,260 shares of Aquestive Therapeutics worth $484K as of Q2 2026.
  • Aquestive Therapeutics was a new GSA Capital Partners position in Q2 2026.
  • Aquestive Therapeutics made up 0.03% of GSA Capital Partners's portfolio in Q2 2026, its #1025 holding.
  • GSA Capital Partners first reported a position in Aquestive Therapeutics in Q1 2019 and has held it in 14 quarters since.
  • GSA Capital Partners's Aquestive Therapeutics position peaked at $1.35M in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.